Yes it is a bad thing but what do you expect after going from .02 to .0004???? Same with Bmsn..If you are expecting actual revenue here then you are in the wrong stock. Biotech companies are extremely expensive to keep up and when they dont even have a drug on the market making money then you are losing money. Both bmsn and entb losing money everyday but that is not why most people are here for. They are here for the potential of profits to be made.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.